Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Randomised Phase II Trial of Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients (=/> 70 Years) With Advanced Non-Small Cell Lung Cancer

NCT00678964 is registered in ClinicalTrials.gov with LungenClinic Grosshansdorf as lead sponsor.

NCT NCT00678964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00678964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Randomised Phase II Trial of Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients (=/> 70 Years) With Advanced Non-Small Cell Lung Cancer
Lead sponsor
LungenClinic Grosshansdorf
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2006
Completion date
Not reported
Enrollment
260 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer